Literature DB >> 6950022

Intragenic recombination in an E beta gene for a murine Ia antigen.

M L Plunkett, J E Coligan, C S David, J H Freed.   

Abstract

The recombinant strain D2.GD was originally typed as I-Ad by serological methods. Indeed, the A alpha and A beta chains of the I-A antigens appear to exhibit normal behavior by the criteria of serology and two dimensional gel analysis. However, the E beta chain encoded by the I-A subregion of this strain, one of the two components of the plasma membrane located I-E antigens produced in D2.GD X A.TFR5)F1 animals, has been demonstrated to be the product of an intragenic recombinational event between E beta genes from the d and b haplotypes. Sequence analysis suggests that the amino-terminal portion of the Eg2 beta chain is derived from the d haplotype and, therefore, that the coding strand for this gene is oriented centromeric leads to telomeric (5' to 3' direction). Finally, these data combined with the data of Rose and Cullen (17) allow the ordering of the genes within the I-A subregion as (H-2K), A alpha, A beta, E beta ... (H-2D).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6950022      PMCID: PMC2186618          DOI: 10.1084/jem.155.3.937

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Chemical characterization of murine Ia alloantigens determined by the i-E/i-C subregions of the H-2 complex.

Authors:  J Silver; W A Russell; B L Reis; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

2.  Serologic and biochemical analyses of a variant Ae (E beta) ia polypeptide chain in D2.gD (H-2g2).

Authors:  W P Lafuse; H I Hendrickson; P S Corser; C S David
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

Review 3.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

4.  Lack of gene complementation prevents expression of I-Ek in recombinant A.TFR5.

Authors:  W P Lafuse; J F McCormick; C S David
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  Structural studies on the murine Ia alloantigens. IV. NH2-terminal sequence analysis of allelic products of the I-A and I-E/C subregions.

Authors:  R G Cook; M H Siegelman; J D Capra; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

6.  A variant alpha-chain in an Ia molecule from the I-A subregion of the mouse major histocompatibility complex: a possible intragenic recombination.

Authors:  S M Rose; S E Cullen
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

7.  Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion.

Authors:  M McMillan; J M Cecka; D B Murphy; H O McDevitt; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Two-gene control of the expression of a murine Ia antigen.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Serological and biochemical identification of hybrid Ia antigens.

Authors:  W P Lafuse; J F McCormick; C S David
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

10.  Aberrant Ae (E beta) Ia polypeptide chain in H-2g2 haplotype mice. Possible result of an intragenic recombination or mutation.

Authors:  P P Jones
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  2 in total

1.  Analysis of the DR beta chains from two DRw6 cell lines (WT46 and WT52): recombination in vivo may have generated new haplotypes.

Authors:  P J Knudsen; J McLean; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Hybrid gamma 2b-gamma 2a genes expressed in myeloma variants: evidence for homologous recombination.

Authors:  S A Tilley; L A Eckhardt; K B Marcu; B K Birshtein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.